. Clinical observations with AN-1792 using TAPIR analyses. Neurodegener Dis. 2005;2(5):273-6. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Will Tau Drug Show Its True Colors in Phase 3 Trials?